Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026)
Stoke Therapeutics (STOK) posted quarterly Prepaid Assets of $6.9 million for Q1 2026, up 36.59% year-over-year from $5.0 million in Q1 2025, and down 21.25% quarter-over-quarter from $8.7 million in Q4 2025.
Analysis
Stoke Therapeutics (STOK) Prepaid Assets (2018 - 2026) Analysis & Trends
Stoke Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 36.59% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 36.59% YoY), while the FY2025 annual figure was $8.7 million, down 21.42% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.9 million, down from $8.7 million in the prior quarter.
- The five-year high for Prepaid Assets was $13.2 million in Q2 2022, with the low at $3.8 million in Q3 2024.
- The 5-year median for Prepaid Assets is $10.7 million (2024), against an average of $9.0 million.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets sank 65.17% in 2024, then jumped 103.39% in 2025.
- Stoke Therapeutics' Prepaid Assets stood at $10.9 million in 2022, then advanced by 3.55% to $11.3 million in 2023, then decreased by 1.79% to $11.1 million in 2024, then declined by 21.42% to $8.7 million in 2025, then declined by 21.25% to $6.9 million in 2026.
- Business Quant data shows STOK's Prepaid Assets at $6.9 million in Q1 2026, $8.7 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.67 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.69 Mn |
| Mar 31, 2026 | 10.12 Mn |
| Dec 31, 2025 | 8.74 Mn |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 13.69 Mn |
| Mar 31, 2025 | 12.69 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Sep 30, 2024 | 9.84 Mn |
| Jun 30, 2024 | 10.35 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 11.32 Mn |
| Sep 30, 2023 | 10.94 Mn |
| Jun 30, 2023 | 10.95 Mn |
| Mar 31, 2023 | 10.19 Mn |
| Dec 31, 2022 | 10.93 Mn |
| Sep 30, 2022 | 12.55 Mn |
| Jun 30, 2022 | 13.18 Mn |
| Mar 31, 2022 | 12.29 Mn |
| Dec 31, 2021 | 6.94 Mn |
| Sep 30, 2021 | 8.47 Mn |